ClinConnect ClinConnect Logo
Search / Trial NCT07070271

Effect of Neurophysiological Facilitation of Respiration on Blood Gases and Hospital Stay in Children With Pneumonia

Launched by ASMAA AHMED ABD EL-SAMAD · Jul 15, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Pneumonia Neurophysiological Facilitation Chest Physical Therapy Blood Gases

ClinConnect Summary

This clinical trial is studying a special breathing technique called neurophysiological facilitation to see if it helps children with pneumonia recover faster. Pneumonia is a lung infection that can make it hard for kids to breathe. The researchers want to find out if this breathing method can improve how well the lungs work (measured by blood oxygen and carbon dioxide levels), reduce how severe the illness is, and shorten the time children need to stay in the hospital.

The trial is open to children between 6 months and 2 years old who have been diagnosed with pneumonia and are medically stable during the study. Children who have serious medical problems, ongoing seizures, or weak bones will not be able to join. If your child participates, they will receive this special breathing support while staying in the hospital, and doctors will carefully monitor their breathing and overall health. This study is not yet enrolling patients but aims to find new ways to help young children recover more quickly from pneumonia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children of both sexes, with age ranged from 6 months to 2 years old.
  • All children diagnosed with pneumonia.
  • All children should be vitally stable during the study period.
  • Exclusion Criteria:
  • Medically unstable children.
  • Children with uncontrolled convulsions.
  • Children with Osteopenia.

About Asmaa Ahmed Abd El Samad

Asmaa Ahmed Abd El-Samad is a clinical research professional dedicated to advancing medical knowledge through the design and management of clinical trials. With a strong focus on ensuring ethical standards and scientific rigor, she contributes to the development of innovative therapies aimed at improving patient outcomes. Her expertise encompasses protocol development, regulatory compliance, and collaborative coordination with multidisciplinary teams to facilitate successful trial execution.

Locations

Giza, , Egypt

Patients applied

0 patients applied

Trial Officials

Asmaa Ahmed Abd El-samad, master's degree

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported